Jiratha Budkaew

Jiratha Budkaew

Auto-generated profile, based on publicly available information

Jiratha Budkaew

Department of Social Medicine, Khon Kaen Center Hospital, Khon Kaen, Thailand

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Pragmatic and Observational Research
Verified
Journal Article
Open access
PDF file
JBJiratha Budkaew
Jiratha Budkaew
BCBandit Chumworathayi
Bandit Chumworathayi
CPChamsai Pientong
Chamsai Pientong
TETipaya Ekalaksananan
Tipaya Ekalaksananan
Background: Many methods are used to detect urethral Neisseria gonorrhea (NG) infection among asymptomatic men who have sex with men (MSM). The objective of this study was to define the performance of conventional culture compared to real-time polymerase chain reaction (PCR) for diagnosis of asymptomatic urethral gonorrhea among MSM. Methods: In this cross-sectional study, 147 clinical specimens for NG testing from asymptomatic participants were evaluated. MSM >18 years old who consented to undergo urethral swab and collection of urine samples from two clinics (one was the sexually transmitted diseases (STDs) mobile clinic and the second was the antiretroviral clinic) located in Khon Kaen, Thailand, were recruited. For conventional culture, 147 swab specimens from urethra were analyzed. For real-time PCR, the same samples and collected urine (147 urethral swab and 62 urine) were evaluated. Results: Participants were predominately older aged (mean age: 28.79 years, range: 18–54), asymptomatic (99.3%), and engaged in sex with multiple partners (63% had at least two partners and 36% had at least three partners during the previous 3 months). Twenty-five MSM (17%) had history of STD, mainly human immunodeficiency virus infection. Of the 147 specimens, 42 were positive for NG detected by real-time PCR (prevalence: 28.6%, 95% confidence ­interval [CI]: 24.8%–32.4%), while none of the 147 MSM were positive for NG detected by conventional culture (prevalence: 0.0%, 95% CI: 0.0%–7.3%). These findings indicated that conventional culture had low sensitivity but high specificity (0.0% and 100%, respectively). We could not demonstrate that many of the factors that were identified in other studies were associated to increased (or decreased) risk of urethral gonococcal infection in our population. Conclusion: In asymptomatic MSM, nucleic acid amplification tests are more appropriate for screening of urethral NG infection than conventional culture. However, the culture method is necessary for monitoring emerging antimicrobial resistance and to inform gonorrhea treatment guidelines.

7 March 2018 in International Journal of STD & AIDS
Verified
Journal Article
Closed access
SHSaowarop Hinkan
Saowarop Hinkan
JCJureeporn Chuerduangphui
Jureeporn Chuerduangphui
TETipaya Ekalaksananan
Tipaya Ekalaksananan
JBJiratha Budkaew
Jiratha Budkaew
KPKanisara Proyrungroj
Kanisara Proyrungroj
CPChamsai Pientong
Chamsai Pientong
Chlamydia trachomatis is a common agent of sexually transmitted infection, especially in asymptomatic extra-genital sites among men who have sex with men (MSM). This study aims to investigate anatomical site distribution and genotypes of C. trachomatis from asymptomatic MSM in northeast Thailand. Specimens were collected using swabs from anorectal, oropharyngeal, and urethral sites in 346 asymptomatic MSM. C. trachomatis infection was determined by real-time polymerase chain reaction and genotyping was based on sequences of the ompA gene. The results showed that infection by C. trachomatis was most common at the urethral site (29.1%, 101/346) followed by oropharyngeal (17.6%, 61/346) and anorectal site (17.0%, 59/346). In addition, C. trachomatis infection was significantly associated with absence of condom use (odds ratio = 1.909, 95%CI = 1.054–3.457, P = 0.033) at the urethral site. Overall 49.4% (171/346) of individuals were infected in at least one site. Infection at only the anorectum, oropharynx, or urethra was seen in 9.0, 9.3, and 18.5% of participants, respectively. Concurrent infections at anorectum/oropharynx, anorectum/urethra, oropharynx/urethra, and all three sites were 2.0, 4.3, 4.6, and 1.7%, respectively. Genotype D predominated at the anorectal and urethral sites among asymptomatic MSM in northeast Thailand. Concurrent infection in two or three anatomical sites occurred. C. trachomatis screening at all three sites in asymptomatic MSM is important and should be considered for proper treatment and prevention of transmission.

12 June 2025 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
SPSirilakkhana Phrawong
Sirilakkhana Phrawong
NSNithikorn Sorncha
Nithikorn Sorncha
JBJiratha Budkaew
Jiratha Budkaew
BCBandit Chumworathayi
Bandit Chumworathayi
Introduction: Type 2 diabetes mellitus (T2DM) is the leading cause of chronic kidney disease (CKD). Thiamine has shown efficacy in microalbuminuria reduction, but its effect on esti-mated glomerular filtration rate (eGFR) is still uncertain. Objective: To determine the effect of thiamine on increasing eGFR in patients with T2DM with CKD stage 3. Methods: This RCT was conducted in 35 T2DM with CKD stage 3 patients. 18 received 300 mg thiamine once daily (150 mg/capsule) and 17 received a placebo for 24 weeks. The primary outcome was the difference in the median change in the eGFR with thiamine at 24 weeks. Secondary outcomes included median changes within and between groups in the serum creatinine level, HbA1C level, urinary albumin level, total cholesterol level, LDL level, HDL level, triglyceride level, and adverse events. Results: The baseline characteristics of the two groups were similar except for body mass index (BMI). After 24 weeks, the median change in eGFR was 1.59 ml/min/1.73 m2 of body-surface area (BSA) in thiamine group as compared to 1.78 ml/min/1.73 m2 of BSA in placebo group, leading to treatment difference of -0.19 ml/min/1.73 m2 of BSA (p = 0.61). The patients who received thiamine had a significant decrease in median HbA1c compared to the placebo (median change difference of -1.35, p < 0.01). The urinary albumin level and all lipid profiles were not significantly different be-tween the two groups. No serious adverse events were reported. Conclusion: The effects of the two agents on eGFR were not significantly different, but patients who received thiamine had a significant decrease in median HbA1C.